Yu Xia insider trades
Open-market stock purchases and sales by Yu Xia, Director at Summit Therapeutics Inc, from SEC Form 4 filings since Jan 2, 2024.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -25%.
Companies traded
- SMMT Summit Therapeutics Inc: 1 buy, last Jan 2, 2026